Date of report : 2024-12-17
Lupus (SLE)
Fondation du Rein, ANR eCellFrance
Summary of the Main Points/Findings
Background and Objective:
This phase 1, dose-escalation trial aimed to assess the safety and preliminary efficacy of allogeneic umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in